홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Tris(hydroxymethyl)aminomethane → Morpholine-4-carboxylic acid (2-cyclopropylmethanesulfonyl-1-{1-[hydroxy-(5-phenyl-1,2,4-oxadiazol-3-yl)-methyl]-propylcarbamoyl}-ethyl)-amide

HRID 489639
인쇄

반응식

HRID 489639 반응식
C1(C2N=C(C(C(N[C:15]([CH:17]([NH:26][C:27]([N:29]3[CH2:34][CH2:33][O:32][CH2:31][CH2:30]3)=[O:28])[CH2:18][S:19]([CH2:22][CH:23]([CH3:25])[CH3:24])(=[O:21])=[O:20])=[O:16])CC)=O)ON=2)CC1.C1(N=C=N)CCCCC1.C1C=CC2N(O)N=NC=2C=1.[NH2:54][CH:55]([CH2:69][CH3:70])[C@@H:56]([C:58]1[N:62]=[C:61]([C:63]2[CH:68]=[CH:67][CH:66]=[CH:65][CH:64]=2)[O:60][N:59]=1)[OH:57].C(O)C(N)(CO)CO>C(Cl)Cl>[CH:23]1([CH2:22][S:19]([CH2:18][CH:17]([NH:26][C:27]([N:29]2[CH2:30][CH2:31][O:32][CH2:33][CH2:34]2)=[O:28])[C:15](=[O:16])[NH:54][CH:55]([CH:56]([OH:57])[C:58]2[N:62]=[C:61]([C:63]3[CH:68]=[CH:67][CH:66]=[CH:65][CH:64]=3)[O:60][N:59]=2)[CH2:69][CH3:70])(=[O:20])=[O:21])[CH2:24][CH2:25]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 5

HCID 6503Tris(hydroxymethyl)aminomethaneHCID 757711-HydroxybenzotriazoleHCID 10239165Morpholine-4-carboxylic acid [1-[1-(3-cyclopropyl-1,2,4-oxadiazole-5-carbonyl)-propylcarbamoyl]-2-(2-methyl-propane-1-sulfonyl)-ethyl]-amideHCID 12048208N-CyclohexylcarbodiimideHCID 67301524(S)-2-Amino-1-(5-phenyl-1,2,4-oxadiazol-3-yl)-butan-1-ol

생성물 1

HCID 86590022
Morpholine-4-carboxylic acid (2-cyclopropylmethanesulfonyl-1-{1-[hydroxy-(5-phenyl-1,2,4-oxadiazol-3-yl)-methyl]-propylcarbamoyl}-ethyl)-amide
수율 109.2%

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

A suspension of (R)-3-cyclopropylmethanesulfonyl-2-[(morpholine-4-carbonyl)-amino]-propionic acid (110 mg, 0.344 mmol, Reference Example 4) in methylene chloride (10 mL) was treated with PS-bound N-cyclohexylcarbodiimide (HL 200-400 mesh cross linked with 2% DVB) from Novabiochem (320 mg, 0.618 mmol, 1.93 mmol/g loading) and stirred at room temperature for 10 minutes. HOBt (43 mg, 0.319 mmol) was added followed by (S)-2-amino-1-(5-phenyl-1,2,4-oxadiazol-3-yl)-butan-1-ol (73 mg, 0.313 mmol, Reference Example 12) and the reaction mixture was stirred at room temperature overnight. PS-trisamine from Argonaut Technologies (413 mg, 1.549 mmol, 3.75 mmol/g loading) was added and the reaction was stirred for another 3 hours. The mixture was filtered and the filtrate was evaporated under reduced pressure to give morpholine-4-carboxylic acid (2-cyclopropylmethanesulfonyl-1-{1-[hydroxy-(5-phenyl-1,2,4-oxadiazol-3-yl)-methyl]-propylcarbamoyl}-ethyl)-amide as an orange solid (183 mg). MS: 536 (MH+)

후처리

  1. stirringthe reaction mixture was stirred at room temperature overnight
  2. stirringthe reaction was stirred for another 3 hours
  3. filtrationThe mixture was filtered
  4. customthe filtrate was evaporated under reduced pressure

출처 및 근거

ORD 기록
ord-78688f5395144f19830c2592a16515b0
출처 데이터셋
uspto-grants-2005_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06977256B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트